SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-003840
Filing Date
2018-02-28
Accepted
2018-02-28 17:05:48
Documents
74
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cort-10k_20171231.htm 10-K 2608602
2 EX-23.1 cort-ex231_8.htm EX-23.1 4177
3 EX-31.1 cort-ex311_6.htm EX-31.1 15195
4 EX-31.2 cort-ex312_9.htm EX-31.2 15185
5 EX-32.1 cort-ex321_10.htm EX-32.1 6808
6 EX-32.2 cort-ex322_7.htm EX-32.2 6784
7 GRAPHIC g2018022821152337527370.jpg GRAPHIC 30118
  Complete submission text file 0001564590-18-003840.txt   9342836

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cort-20171231.xml EX-101.INS 2287648
9 XBRL TAXONOMY EXTENSION SCHEMA cort-20171231.xsd EX-101.SCH 52043
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20171231_cal.xml EX-101.CAL 62000
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20171231_def.xml EX-101.DEF 137103
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20171231_lab.xml EX-101.LAB 427543
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20171231_pre.xml EX-101.PRE 318258
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 18652375
SIC: 2834 Pharmaceutical Preparations